Fibromyalgia is a chronic pain illness marked by musculoskeletal discomfort, tiredness, and mood swings. There is little evidence on the effect of medical cannabis (MC) medication on fibromyalgia sufferers. For a study, researchers explored the efficacy of using medical cannabis for the treatment of fibromyalgia. Data on individuals with fibromyalgia who were treated with MC were gathered from the registries of two Israeli hospitals (Laniado Hospital and Nazareth Hospital). After receiving the patient’s permission, demographic, clinical, and laboratory data were recorded. In addition, all patients completed the Revised Fibromyalgia Impact Questionnaire before and after MC therapy.

Among 30 patients  identified, 26 participated in the trial. The research group consisted of 19 female patients (73%), with a mean age of 37.8 (± 7.6). The average MC dosage was 26 (± 8.3) g per month, and the average length of MC use was 10.4 (± 11.3) months. After starting MC therapy, all patients reported a substantial improvement in all questionnaire parameters, and 13 patients (50%) ceased taking any other fibromyalgia drugs. Eight individuals (30%) encountered minor side effects.

Medical cannabis therapy demonstrated a considerable positive effect on fibromyalgia patients, with few side effects.